{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T07:37:03Z","timestamp":1782459423678,"version":"3.54.5"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,5]]},"abstract":"<jats:p>Durable ventricular assist device (VAD) therapy remains an important treatment for end-stage heart failure. Despite advancements in device design, postimplant infectious complications continue to plague this population. In this study, we aim to evaluate the use of durable VAD therapy in patients on active immunosuppression. All patients undergoing durable, continuous-flow VAD placement on active immunosuppression at our center from 2004 to 2012 were included in the analysis (group immunosuppressed [IS]; n = 13). Demographic data, comorbidities, device details, immunosuppression details including indication, postimplant infections, and outcomes were collected and compared with patients without immunosuppression (group non-IS; n = 259). Mean age in the IS group was 56.3\u2009\u00b1\u200912.4 years, and 12 patients (92.3%) were male. Twelve patients (92.3%) were implanted as a bridge to transplant. Incidence of any postimplant infection and device-related infection was 1.15 infections\/patient \u00d7 year and 0.38 infections\/patient \u00d7 year, respectively. Survival to discharge was 84.6% and 93.1% (<jats:italic toggle=\"yes\">p<\/jats:italic> = 0.25), and 1 year survival was 75.0% and 83.1% (<jats:italic toggle=\"yes\">p<\/jats:italic> = 0.47) in the IS and non-IS group, respectively. Mean duration of support was 384\u2009\u00b1\u2009466 days, and mean follow-up was 2.1\u2009\u00b1\u20091.5 years. Active immunosuppression may lead to a modest increase in postimplant infection rate in durable VAD patients than in non-IS patients undergoing the same treatment; however, late on-device survival is not affected. Immunosuppression should not be considered an absolute contraindication to device implant.<\/jats:p>","DOI":"10.1097\/mat.0000000000000653","type":"journal-article","created":{"date-parts":[[2017,9,6]],"date-time":"2017-09-06T16:38:09Z","timestamp":1504715889000},"page":"334-337","source":"Crossref","is-referenced-by-count":1,"title":["Use of Durable Continuous-Flow Ventricular Assist Devices in Patients on Immunosuppression"],"prefix":"10.1097","volume":"64","author":[{"given":"Robert A.","family":"Sorabella","sequence":"first","affiliation":[{"name":"Division of Cardiothoracic Surgery, Columbia University College of Physicians and Surgeons, New York, New York and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiho","family":"Han","sequence":"additional","affiliation":[{"name":"Division of Cardiothoracic Surgery, Columbia University College of Physicians and Surgeons, New York, New York and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veli K.","family":"Topkara","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Columbia University College of Physicians and Surgeons, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Reshad","family":"Garan","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Columbia University College of Physicians and Surgeons, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melana","family":"Yuzefpolskaya","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Columbia University College of Physicians and Surgeons, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo C.","family":"Colombo","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Columbia University College of Physicians and Surgeons, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Takeda","sequence":"additional","affiliation":[{"name":"Division of Cardiothoracic Surgery, Columbia University College of Physicians and Surgeons, New York, New York and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshifumi","family":"Naka","sequence":"additional","affiliation":[{"name":"Division of Cardiothoracic Surgery, Columbia University College of Physicians and Surgeons, New York, New York and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroo","family":"Takayama","sequence":"additional","affiliation":[{"name":"Division of Cardiothoracic Surgery, Columbia University College of Physicians and Surgeons, New York, New York and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230821","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.healun.2012.05.004","article-title":"Continuous-flow devices and percutaneous site infections: Clinical outcomes.","volume":"31","author":"Goldstein","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"R2-20230821","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jtcvs.2010.03.037","article-title":"Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: Impact of duration of left ventricular assist device support and other variables.","volume":"140","author":"John","year":"2010","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R3-20230821","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.athoracsur.2012.10.080","article-title":"Impact of ventricular assist device complications on posttransplant survival: An analysis of the United network of organ sharing database.","volume":"95","author":"Healy","year":"2013","journal-title":"Ann Thorac Surg"},{"key":"R4-20230821","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.athoracsur.2012.05.074","article-title":"Driveline infections in left ventricular assist devices: Implications for destination therapy.","volume":"94","author":"Sharma","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"R5-20230821","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.healun.2011.01.717","article-title":"Working formulation for the standardization of definitions of infections in patients using ventricular assist devices.","volume":"30","author":"Hannan","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"R6-20230821","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.healun.2012.12.004","article-title":"Fifth INTERMACS annual report: Risk factor analysis from more than 6,000 mechanical circulatory support patients.","volume":"32","author":"Kirklin","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"R7-20230821","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.healun.2010.08.003","article-title":"Infectious complications after pulsatile-flow and continuous-flow left ventricular assist device implantation.","volume":"30","author":"Schaffer","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"R8-20230821","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.humimm.2009.10.012","article-title":"Peripheral blood mononuclear cell transcriptome profiles suggest T-cell immunosuppression after uncomplicated mechanical circulatory support device surgery.","volume":"71","author":"Sinha","year":"2010","journal-title":"Hum Immunol"},{"key":"R9-20230821","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0140-6736(98)10359-8","article-title":"Activation-induced T-cell death and immune dysfunction after implantation of left-ventricular assist device.","volume":"354","author":"Ankersmit","year":"1999","journal-title":"Lancet"},{"key":"R10-20230821","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1016\/j.athoracsur.2008.01.050","article-title":"Cellular immunity impaired among patients on left ventricular assist device for 6 months.","volume":"85","author":"Kimball","year":"2008","journal-title":"Ann Thorac Surg"},{"issue":"6 suppl","key":"R11-20230821","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/S0003-4975(03)00480-6","article-title":"Interactions between the recipient immune system and the left ventricular assist device surface: Immunological and clinical implications.","volume":"75","author":"Itescu","year":"2003","journal-title":"Ann Thorac Surg"}],"container-title":["ASAIO Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00002480-201805000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T02:31:09Z","timestamp":1692671469000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002480-201805000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":11,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/mat.0000000000000653","relation":{},"ISSN":["1058-2916"],"issn-type":[{"value":"1058-2916","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]}}}